Target Price Playground

MRNA
$223.37
Gamma & Research: Call Wall: $230 (+3.0%) Put Wall: $220 (-1.5%) True IV %ile: 30.5% Flow: BEARISH (40% Bull)
๐ŸŸข
MRNA IV: 71.2% โ€” LOW (-38.8% vs 30d avg of 116.4%)
Options are cheap vs 30d avg โ€” good time to BUY options (long calls/puts, debit spreads).

๐Ÿ“‹ Strategy

Own stock, sell OTM call for income. Caps upside.

๐ŸŽฏ Target

1-Click Institutional Target Anchors:
60d from today

โš™๏ธ Legs

LONG 100 SHARES
@ $223.37 ยท ฮ” 1.00
SHORT CALL ยท $240 ยท Jan '27
Qty 1 ยท Premium $24.62 ยท ฮ” 0.49
P&L at Expiry Now $223 Target $241 $156 $223 $290
Stock (100 sh) Covered Call Now Target
๐Ÿ’ก Stock vs Options at Target

If MRNA hits $241 by Jan 15: the covered call returns +$4,125 (20.8%) on $19,875 risked, vs +$1,787 (8.0%) for 100 shares on $22,337. Options give 2.6ร— capital efficiency.

๐Ÿ“… Expiry & Gamma Wall Alignment

Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if MRNA is at $241.
Tip: For Covered Calls, selling strikes at or above the $230 Call Wall captures dealer overhead resistance; for Cash-Secured Puts, selling at or below the $220 Put Wall aligns with dealer support.

๐Ÿ“Š Projected Return

P&L if MRNA hits $241 by Jan 15
+$4,125
+20.8% on $19,875 risked
Max Profit
+$4,125
If the stock โ‰ฅ $240 at expiry
Max Loss
โˆ’$19,875
If stock โ†’ $0 (minus premium received)
Break-even
$198.75
-11.02% from spot
Prob. of Profit at Expiry (PoP)
59.5%
Above breakeven ($198.75) ยท Touch Target: 80%
Net ฮ” / ฮ˜ / V
50.6 / 25.51 / -37.56
per spread, per $1 move / day / vol pt
๐Ÿ’พ Log in to save ๐Ÿ“Š My Saved Strategies

๐Ÿ“Š P&L Scenarios โ€” what happens at different prices and dates

MRNA Price Today Dec 6 Dec 26 Jan 15 (exp)
$179 (-20%) -$2,819 -$2,469 -$2,141 -$2,005
$190 (-15%) -$2,012 -$1,589 -$1,145 -$889
$201 (-10%) -$1,272 -$782 -$222 +$228
$212 (-5%) -$602 -$55 +$610 +$1,345
$219 (-2%) -$233 +$342 +$1,059 +$2,015
$223 (0%) โ† spot +$0 +$591 +$1,337 +$2,462
$228 (+2%) +$222 +$826 +$1,598 +$2,909
$235 (+5%) +$536 +$1,156 +$1,954 +$3,579
$241 (+8%) โ† target +$827 +$1,458 +$2,272 +$4,125
$246 (+10%) +$1,010 +$1,645 +$2,463 +$4,125
$257 (+15%) +$1,425 +$2,062 +$2,871 +$4,125
$268 (+20%) +$1,787 +$2,415 +$3,189 +$4,125
Uses MRNA's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.